By Kathleen Gallagher of the Journal Sentinel
Cellular Dynamics International and Roche have expanded their drug development testing agreement, the companies said Wednesday.
For the next two years, Madison-based Cellular Dynamics will supply heart cells to Roche, and the companies will collaborate to perform various tests on the cells. The agreement expands one forged in March 2008, the companies said.
Cellular Dynamics, known as CDI, grows induced pluripotent cells from human tissue. They have all the characteristics of embryonic stem cells, which means they can turn into beating heart cells or liver cells or any other cells in the human body.
